Qu BiologicsQu Biologics is a clinical stage biotechnology company developing Site Specific Immunomodulators (SSI), a novel class of immunotherapies designed to restore innate immune function in targeted organs to reverse the immune dysregulation underlying many important diseases including cancer, chronic inflammatory diseases, and infection. Qu Biologics has completed four Phase 2 studies in lung cancer, Crohn’s disease, and ulcerative colitis. Two additional Phase 2 randomized placebo-controlled studies, in late-stage colon cancer and immunosenescence, have received regulatory and ethics approval. |
Website www.qubiologics.com Phone 604.734.1450 Address Qu Biologics Inc. 4475 Wayburne Drive, Suite 305 Burnaby, B.C., Canada V5G 4X4 |